“Projections of the Cost of Cancer Care in the United States: 2010–2020” by Mariotto et al. [J Natl Cancer Inst 2010; 103(2): 117-128]. Percentages in column 5 of Table 3 were entered incorrectly. The correct version of Table 3 appears below. The Journal and the authors regret the error.
Table 3.
United States cancer prevalence estimates for 2010 and projections for 2020 under different scenario assumptions*
| Number of cancer survivors |
|||||
| 2010 | 2020 |
||||
| Site | Base | Base, No. (% change) | Trend incidence, No. (% change) | Trend survival, No. (% change) | Trend incidence & survival, No. (% change) |
| Bladder | 514 000 | 629 000 (22) | 576 000 (12) | 640 000 (25) | 587 000 (14) |
| Brain | 139 000 | 176 000 (27) | 174 000 (25) | 185 000 (33) | 182 000 (31) |
| Breast | 3 461 000 | 4 538 000 (31) | 4 275 000 (24) | 4 597 000 (33) | 4 329 000 (25) |
| Cervix | 281 000 | 276 000 (−2) | 245 000 (−13) | 277 000 (−1) | 245 000 (−13) |
| Colorectal | 1 216 000 | 1 517 000 (25) | 1 327 000 (9) | 1 575 000 (30) | 1 376 000 (13) |
| Esophagus | 35 000 | 50 000 (43) | 48 000 (37) | 62 000 (77) | 60 000 (71) |
| Head/Neck | 283 000 | 340 000 (20) | 308 000 (9) | 346 000 (22) | 313 000 (11) |
| Kidney | 308 000 | 426 000 (38) | 487 000 (58) | 446 000 (45) | 511 000 (66) |
| Leukemia | 263 000 | 340 000 (29) | 328 000 (25) | 356 000 (35) | 342 000 (30) |
| Lung | 374 000 | 457 000 (22) | 392 000 (5) | 481 000 (29) | 412 000 (10) |
| Lymphoma | 639 000 | 812 000 (27) | 803 000 (26) | 841 000 (32) | 831 000 (30) |
| Melanoma | 1 225 000 | 1 714 000 (40) | 1 971 000 (61) | 1 724 000 (41) | 1 983 000 (62) |
| Ovary | 238 000 | 282 000 (18) | 232 000 (-3) | 296 000 (24) | 241 000 (1) |
| Pancreas | 30 000 | 40 000 (33) | 40 000 (33) | 50 000 (67) | 50 000 (67) |
| Prostate | 2 311 000 | 3 265 000 (41) | 3 108 000 (34) | 3 291 000 (42) | 3 132 000 (36) |
| Stomach | 74 000 | 93 000 (26) | 80 000 (8) | 103 000 (39) | 88 000 (19) |
| Uterus | 586 000 | 672 000 (15) | 638 000 (9) | 667 000 (14) | 634 000 (8) |
| All sites | 13 772 000 | 18 071 000 (31) | 17 465 000 (27) | 18 878 000 (37) | 18 229 000 (32) |
Scenarios: base, incidence trend, survival trend, and incidence and survival trend. Percent change from 2010 base estimate.The 2020 estimates under the base scenario represent prevalence estimates under the assumption of flat incidence and survival trends but dynamic changes in the US population. Incidence trend and survival trend scenarios represent prevalence projections under the assumptions that survival and incidence trends will continue as observed in the last years of data. Incidence trends represent changes due to prevention and risk factor prevalence. Survival trends represent changes in early detection and treatment.